Bobby McMillin Discusses Biosecure Act in STAT
Arnold & Porter Legislative & Public Policy partner Bobby McMillin was recently quoted by STAT discussing the impact of the Biosecure Act and the potential for additional legislative and regulatory…
Read the full articleYou might also wanna read
The case for bioliteracy: Exploring biotech’s role in national security
The continued faceoff between WuXi AppTec and the US government highlights the need for a biotech-savvy citizenry.
RFK Jr.'s GRAS loophole crackdown raises concerns over regulatory disruption
Health Secretary Robert F. Kennedy Jr. has built much of his public health platform around exposing what he calls regulatory failures in the
rawstory.com·15d ago
AI industry leaders unite to urge US lawmakers on bioweapon safeguards
AI industry rivals rarely agree, but they’re all concerned their technology could be used to develop biological weapons.
The Verge·1mo agoAI industry leaders unite to urge US lawmakers on bioweapon safeguards
AI industry rivals rarely agree, but they’re all concerned their technology could be used to develop biological weapons.
theverge.com·1mo ago
The Battle for AI Legislation: Industry PACs Clash in Washington
As lawmakers craft AI legislation, two major industry PACs present contrasting visions, each vying for influence in shaping the regulatory f
Offense, Not Defense: How US Biodefense Agencies Broke the 1972 Bioweapons Treaty
Newly declassified DNI documents expose a biological weapons program veiled as pandemic preparedness, while the former NIAID director faces
AI and biotech leaders urge US Congress to regulate synthetic DNA sales over bioweapon concerns
Synthetic DNA can be used for vaccines, but it can also create bioweapons. Tech giants and biotechnology experts are asking for stronger reg
euronews.com·1mo ago
Comments
Sign in to join the conversation.
No comments yet. Be the first.